Eupraxia Pharmaceuticals EPRX

NASDAQ EPRX

$7.64 +0.14 (+1.80%)

As of: Sep 4, 2026 · 1:07 PM EDT

Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (QoQ) (2023 - 2024)

Analysis

Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (QoQ) (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.27 Bn	131.42 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.55 Bn	77.56 Bn	3.93 Bn
3	Argenx Se	63.45 Bn	58.27 Bn	1.37 Bn
4	Moderna	57.73 Bn	52.59 Bn	52.00 Mn
5	Revolution Medicines	44.08 Bn	44.08 Bn	-
6	BeOne Medicines	39.95 Bn	34.85 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.14 Bn	31.84 Bn	992.69 Mn
8	Royalty Pharma	28.44 Bn	27.60 Bn	-
9	Insmed	27.32 Bn	26.16 Bn	358.27 Mn
10	Eupraxia Pharmaceuticals	305.07 Mn	305.07 Mn	-

Historic Data

Historic Data

Download Data

Date	Value
Dec 31, 2024	313.75%
Sep 30, 2024	58,860.99%
Jun 30, 2024	11.79%
Jun 30, 2023	123.04%

Eupraxia Pharmaceuticals

NASDAQ: EPRX

$7.64 ▲ +0.14 (+1.80%)

Sep 4, 2026 · 1:07 PM EDT